Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Hyperlipidaemia
ADR ID BADD_A06050
ADR Hierarchy
14      Metabolism and nutrition disorders
14.08      Lipid metabolism disorders
14.08.03      Hyperlipidaemias NEC
14.08.03.001      Hyperlipidaemia
Description Conditions with excess LIPIDS in the blood. | Abnormally high level of lipids in blood. [MeSH]
MedDRA Code 10062060
MeSH ID D006949; D006951
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE)
Synonym
Hyperlipaemia | Hyperlipemia | Hyperlipidaemia NOS | Hyperlipidaemia secondary | Hyperlipidaemia, other and unspecified | Hyperlipidemia | Hyperlipoproteinemia | Other and unspecified hyperlipidaemia | Other and unspecified hyperlipidemia | Hyperlipidemia secondary | Hyperlipoproteinaemia | Hyperlipidaemia | Lipemia | Lipaemia | Hyperlipidemias | Hyperlipemias | Lipidemia | Lipidemias | Lipemias
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01266Levobetaxolol hydrochloride--
BADD_D01285Levothyroxine0.000015%
BADD_D01292Linagliptin--
BADD_D01300Lisinopril--
BADD_D01318Lorazepam0.000031%
BADD_D01378Memantine--
BADD_D01379Memantine hydrochloride--
BADD_D01442Metoclopramide0.000196%
BADD_D01445Metoprolol0.000017%
BADD_D01476Mirtazapine0.000080%
BADD_D01501Moxifloxacin--
BADD_D01502Moxifloxacin hydrochloride--
BADD_D01507Mycophenolate mofetil--
BADD_D01508Mycophenolic acid0.001427%
BADD_D01530Nandrolone decanoate--
BADD_D01535Naratriptan--
BADD_D01536Naratriptan hydrochloride--
BADD_D01550Nelfinavir mesylate--
BADD_D01567Nilotinib0.002899%
BADD_D01599Olanzapine0.000526%
BADD_D01602Olmesartan--
BADD_D01603Olmesartan medoxomil--
BADD_D01611Omega-3-acid ethyl esters--
BADD_D01617Ondansetron0.000032%
BADD_D01654Palbociclib0.000839%
BADD_D01668Pantoprazole--
BADD_D01799Ponatinib0.000280%
BADD_D01804Posaconazole--
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
The 3th Page    First    Pre   3 4 5    Next   Last    Total 5 Pages